Intelligent Bio Solutions Inc (INBS): Enterprise Value to EBITDA Ratio
The development of Intelligent Bio Solutions (INBS) is constrained by device certification challenges and potential claims regarding the quality of rapid tests. Business success relies on the accuracy of non-invasive diagnostics and the willingness of companies to implement portable fingerprint scanners. This price chart, where the indicator stands at 0.00, highlights financial instability driven by a liquidity shortage and high product promotion expenses, forcing the company to raise external capital.
Comprehensive metric breakdowns and analytics for ibs.inc (INBS)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Intelligent Bio Solutions|INBS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Intelligent Bio Solutions Inc.|INBS - Company Total Debt|Debts to Book Capitalization INBS|INBS - Long-Term Debt|Company Short-Term Debts Intelligent Bio Solutions|Quick Ratio ibs.inc
- financial results and valuation multiples details:
INBS - Net Financial Result|Projected Future Earnings Intelligent Bio Solutions|INBS - Price to Earnings Ratio|Forward P/E Multiple Intelligent Bio Solutions Inc.|INBS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INBS|INBS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Intelligent Bio Solutions|INBS - Earnings per share for the trailing year|Quarterly EPS earnings growth ibs.inc|INBS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Intelligent Bio Solutions
Analysis of all company metrics:Intelligent Bio INBS
The EV/EBITDA multiple compares the total enterprise value of Intelligent Bio Solutions (INBS) to its operating profit before depreciation, taxes, and interest, allowing for an assessment of the business's real value regardless of its debt load. By analyzing the current EV/EBITDA multiple of the business on GURU.Markets, an investor can determine the extent to which the market is overvaluing the potential of non-invasive fingerprint diagnostics amid shifting credit rates.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|Enterprise Value to Operating Income Before Depreciation NARI (Inari Medical Inc)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|Enterprise Value to Operating Income Before Depreciation Ratio RSLS|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
